ATHA: Athira Pharma Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Athira Pharma Inc (ATHA).
$22.69M Market Cap.
ATHA Market Cap. (MRY)
ATHA Shares Outstanding (MRY)
ATHA Assets (MRY)
Total Assets
$58.78M
Total Liabilities
$13.94M
Total Investments
$2.84M
ATHA Income (MRY)
Revenue
$0
Net Income
-$96.94M
Operating Expense
$100.90M
ATHA Cash Flow (MRY)
CF Operations
-$97.17M
CF Investing
$54.83M
CF Financing
$194.00K
ATHA Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $58,779,000 (-63.32%) | $160,245,000 (-37.93%) | $258,153,000 (-22.24%) | $332,008,000 (18.76%) |
Assets Current | $54,841,000 (-64.56%) | $154,729,000 (-25.44%) | $207,533,000 (-20.42%) | $260,799,000 (35.59%) |
Assets Non-Current | $3,938,000 (-28.61%) | $5,516,000 (-89.10%) | $50,620,000 (-28.91%) | $71,209,000 (-18.36%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $44,841,000 (-65.56%) | $130,188,000 (-44.63%) | $235,137,000 (-26.77%) | $321,084,000 (17.06%) |
Property Plant & Equipment Net | $3,252,000 (-26.71%) | $4,437,000 (-16.53%) | $5,316,000 (1.90%) | $5,217,000 (45.52%) |
Cash & Equivalents | $49,069,000 (-46.21%) | $91,215,000 (-5.36%) | $96,386,000 (-12.80%) | $110,537,000 (82.33%) |
Accumulated Other Comprehensive Income | $1,000 (100.29%) | -$349,000 (82.16%) | -$1,956,000 (-404.12%) | -$388,000 (-1275.76%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $2,837,000 (-95.01%) | $56,835,000 (-61.91%) | $149,207,000 (-28.66%) | $209,158,000 (0.77%) |
Investments Current | $2,837,000 (-95.01%) | $56,835,000 (-45.55%) | $104,378,000 (-27.12%) | $143,222,000 (15.45%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $44,829,000 (-32.01%) | $65,936,000 (-21.04%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $1,227,000 (-47.47%) | $2,336,000 (79.69%) |
Trade & Non-Trade Payables | $319,000 (147.29%) | $129,000 (-94.84%) | $2,501,000 (341.09%) | $567,000 (-51.04%) |
Accumulated Retained Earnings (Deficit) | -$406,146,000 (-31.35%) | -$309,206,000 (-61.44%) | -$191,534,000 (-99.73%) | -$95,895,000 (-133.65%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $1,217,000 (-23.22%) | $1,585,000 (-17.06%) | $1,911,000 (-0.47%) | $1,920,000 (92.00%) |
Debt Current | $414,000 (12.50%) | $368,000 (12.88%) | $326,000 (13.19%) | $288,000 (132.26%) |
Debt Non-Current | $803,000 (-34.02%) | $1,217,000 (-23.22%) | $1,585,000 (-2.88%) | $1,632,000 (86.30%) |
Total Liabilities | $13,938,000 (-53.63%) | $30,057,000 (30.59%) | $23,016,000 (110.69%) | $10,924,000 (106.85%) |
Liabilities Current | $13,135,000 (-54.46%) | $28,840,000 (34.57%) | $21,431,000 (130.64%) | $9,292,000 (110.94%) |
Liabilities Non-Current | $803,000 (-34.02%) | $1,217,000 (-23.22%) | $1,585,000 (-2.88%) | $1,632,000 (86.30%) |
ATHA Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $26,093,000 (-21.65%) | $33,304,000 (2.31%) | $32,552,000 (53.34%) | $21,228,000 (216.41%) |
Research & Development Expense | $70,682,000 (-24.64%) | $93,790,000 (52.59%) | $61,464,000 (43.63%) | $42,794,000 (222.10%) |
Operating Expenses | $100,902,000 (-19.58%) | $125,466,000 (20.62%) | $104,016,000 (62.47%) | $64,022,000 (220.19%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$96,940,000 (17.62%) | -$117,672,000 (-23.04%) | -$95,639,000 (-74.36%) | -$54,853,000 (-174.88%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$96,940,000 (17.62%) | -$117,672,000 (-23.04%) | -$95,639,000 (-74.36%) | -$54,853,000 (-174.88%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$96,940,000 (17.62%) | -$117,672,000 (-23.04%) | -$95,639,000 (-74.36%) | -$54,853,000 (-174.88%) |
Weighted Average Shares | $38,480,875 (1.21%) | $38,020,182 (0.76%) | $37,733,240 (2.20%) | $36,921,172 (208.53%) |
Weighted Average Shares Diluted | $38,480,875 (1.21%) | $38,020,182 (0.76%) | $37,733,240 (2.20%) | $36,921,172 (208.53%) |
Earning Before Interest & Taxes (EBIT) | -$96,940,000 (17.62%) | -$117,672,000 (-23.04%) | -$95,639,000 (-74.36%) | -$54,853,000 (-174.88%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$100,902,000 (19.58%) | -$125,466,000 (-20.62%) | -$104,016,000 (-62.47%) | -$64,022,000 (-220.19%) |
ATHA Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $54,830,000 (-42.34%) | $95,089,000 (64.90%) | $57,664,000 (1513.68%) | -$4,079,000 (98.06%) |
Net Cash Flow from Financing | $194,000 (-60.65%) | $493,000 (-24.62%) | $654,000 (-99.33%) | $97,089,000 (-66.84%) |
Net Cash Flow from Operations | -$97,170,000 (3.56%) | -$100,753,000 (-39.03%) | -$72,469,000 (-68.15%) | -$43,098,000 (-78.73%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$42,146,000 (-715.05%) | -$5,171,000 (63.46%) | -$14,151,000 (-128.35%) | $49,912,000 (-14.78%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $54,863,000 (-42.49%) | $95,393,000 (62.22%) | $58,805,000 (2446.57%) | -$2,506,000 (98.79%) |
Capital Expenditure | -$33,000 (89.14%) | -$304,000 (73.36%) | -$1,141,000 (27.46%) | -$1,573,000 (32.20%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $194,000 (-60.65%) | $493,000 (-24.62%) | $654,000 (-99.33%) | $97,089,000 (-53.58%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $11,049,000 (4.01%) | $10,623,000 (0.16%) | $10,606,000 (129.42%) | $4,623,000 (630.33%) |
Depreciation Amortization & Accretion | $1,211,000 (2.37%) | $1,183,000 (12.88%) | $1,048,000 (65.30%) | $634,000 (31600.00%) |
ATHA Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -132.60% (-91.90%) | -69.10% (-95.20%) | -35.40% (-121.25%) | -16.00% (-1.91%) |
Return on Average Assets (ROAA) | -99.50% (-66.11%) | -59.90% (-78.27%) | -33.60% (-115.38%) | -15.60% (-9.86%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -2613.80% (-1405.65%) | -173.60% (-216.21%) | -54.90% (-126.86%) | -24.20% (-30.81%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.23 (70.36%) | -0.79 (37.27%) | -1.25 (85.67%) | -8.74 (57.36%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 0.51 (-28.73%) | 0.71 (39.22%) | 0.51 (-66.36%) | 1.52 (-62.62%) |
Debt to Equity Ratio (D/E) | 0.31 (34.63%) | 0.23 (135.71%) | 0.1 (188.24%) | 0.03 (78.95%) |
Earnings Per Share (EPS) | -2.52 (18.45%) | -3.09 (-22.13%) | -2.53 (-69.80%) | -1.49 (10.78%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -2.53 (4.97%) | -2.66 (-36.24%) | -1.95 (-61.24%) | -1.21 (45.22%) |
Book Value Per Share (BVPS) | 1.17 (-65.98%) | 3.42 (-45.06%) | 6.23 (-28.33%) | 8.7 (-62.06%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.53 (-63.77%) | 4.21 (-38.40%) | 6.84 (-23.91%) | 8.99 (-61.51%) |
Enterprise Value Over EBIT (EV/EBIT) | 1 (0%) | 0 (0%) | 0 (0%) | -7 (85.42%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.56 (286.11%) | 0.14 (139.34%) | -0.37 (94.80%) | -7.03 (85.20%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 4.17 (-22.18%) | 5.37 (-44.60%) | 9.68 (-65.50%) | 28.07 (-35.72%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$97,203,000 (3.81%) | -$101,057,000 (-37.29%) | -$73,610,000 (-64.78%) | -$44,671,000 (-69.00%) |
Enterprise Value (EV) | -$53,227,855 (-216.45%) | -$16,820,363 (-148.55%) | $34,647,897 (-90.91%) | $381,343,885 (-59.77%) |
Earnings Before Tax (EBT) | -$96,940,000 (17.62%) | -$117,672,000 (-23.04%) | -$95,639,000 (-74.36%) | -$54,853,000 (-174.88%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$95,729,000 (17.82%) | -$116,489,000 (-23.15%) | -$94,591,000 (-74.46%) | -$54,219,000 (-171.73%) |
Invested Capital | -$2,208,000 (-105.29%) | $41,775,000 (-70.63%) | $142,247,000 (-33.56%) | $214,099,000 (-0.67%) |
Working Capital | $41,706,000 (-66.87%) | $125,889,000 (-32.35%) | $186,102,000 (-26.01%) | $251,507,000 (33.83%) |
Tangible Asset Value | $58,779,000 (-63.32%) | $160,245,000 (-37.93%) | $258,153,000 (-22.24%) | $332,008,000 (18.76%) |
Market Capitalization | $22,687,145 (-75.47%) | $92,472,637 (-22.89%) | $119,918,897 (-75.36%) | $486,684,885 (-56.26%) |
Average Equity | $73,125,250 (-57.05%) | $170,264,000 (-36.94%) | $269,982,000 (-21.24%) | $342,811,750 (169.34%) |
Average Assets | $97,434,000 (-50.40%) | $196,441,250 (-30.91%) | $284,337,750 (-19.27%) | $352,219,250 (150.02%) |
Invested Capital Average | $3,708,750 (-94.53%) | $67,771,000 (-61.13%) | $174,342,750 (-23.24%) | $227,132,500 (110.36%) |
Shares | 38,669,073 (1.61%) | 38,054,583 (0.60%) | 37,829,305 (1.28%) | 37,351,104 (14.98%) |
